Works matching AU Gerrits, Mireille

Results: 9

Health benefits of combined oral contraceptives - a narrative review.

Published in:

European Journal of Contraception & Reproductive Health Care, 2024, v. 29, n. 2, p. 40, doi. 10.1080/13625187.2024.2317295

By:

Coelingh Bennink, Herjan J. T.;
van Gennip, Femke A. M.;
Gerrits, Mireille G. F.;
Egberts, Jan F. M.;
Gemzell-Danielsson, Kristina;
Kopp-Kallner, Helena

Publication type:

Article

Valproate Reduces the Glucuronidation of Asenapine Without Affecting Asenapine Plasma Concentrations.

Published in:

Journal of Clinical Pharmacology, 2012, v. 52, n. 5, p. 757, doi. 10.1177/0091270011404028

By:

Gerrits, Mireille G.F.;
de Greef, Rik;
Dogterom, Peter;
Peeters, Pierre A.M.

Publication type:

Article

Safety and Pharmacokinetics of ReN1869: A First Human Dose Study in Healthy Subjects after Single-Dose Administration.

Published in:

Journal of Clinical Pharmacology, 2003, v. 43, n. 1, p. 66, doi. 10.1177/0091270002239708

By:

Skrumsager, Birte K.;
Ingwersen, Steen H.;
Gerrits, Mireille

Publication type:

Article

Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study.

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 5, p. 1204, doi. 10.1111/cts.13238

By:

Boettcher, Michael;
Mikus, Gerd;
Trenk, Dietmar;
Düngen, Hans‐Dirk;
Donath, Frank;
Werner, Nikos;
Karakas, Mahir;
Besche, Nina;
Schulz‐Burck, Dominik;
Gerrits, Mireille;
Hung, James;
Becker, Corina

Publication type:

Article

Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers.

Published in:

Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 337, doi. 10.1007/s40262-020-00935-6

By:

Boettcher, Michael;
Loewen, Stephanie;
Gerrits, Mireille;
Becker, Corina

Publication type:

Article

Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies.

Published in:

Clinical Pharmacokinetics, 2020, v. 59, n. 11, p. 1407, doi. 10.1007/s40262-020-00895-x

By:

Boettcher, Michael;
Gerisch, Michael;
Lobmeyer, Maximilian;
Besche, Nina;
Thomas, Dirk;
Gerrits, Mireille;
Lemmen, Julia;
Mueck, Wolfgang;
Radtke, Martin;
Becker, Corina

Publication type:

Article

Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.

Published in:

British Journal of Clinical Pharmacology, 2002, v. 53, n. 3, p. 284, doi. 10.1046/j.0306-5251.2001.01181.x

By:

Skrumsager, Birte K;
Kiehr, Benedicte;
Pedersen, Poul Christian;
Gerrits, Mireille;
Watson, Norma;
Bjarnason, Ketil

Publication type:

Article

An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.

Published in:

European Journal of Clinical Pharmacology, 2001, v. 57, n. 2, p. 143, doi. 10.1007/s002280100273

By:

Tamminga, Wim J.;
Wemer, Johan;
Oosterhuis, Berend;
Brakenhoff, Jan P. G.;
Gerrits, Mireille G. F.;
de Zeeuw, Rokus A.;
de Leij, Lou F. M. H.;
Jonkman, Jan H. G.

Publication type:

Article

First Evidence of Ovulation Induced by Oral LH Agonists in Healthy Female Volunteers of Reproductive Age.

Published in:

2013

By:

Gerrits, Mireille;
Mannaerts, Bernadette;
Kramer, Hester;
Addo, Samira;
Hanssen, Rob

Publication type:

Journal Article